Skip to main content

Advertisement

SpringerLink
Log in

The role of estrogen receptor α in the regulation of bone and growth plate cartilage

  • Review
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

Abstract

Estrogens are important endocrine regulators of skeletal growth and maintenance in both females and males. Studies have demonstrated that the estrogen receptor (ER)-α is the main mediator of these estrogenic effects in bone. Therefore, estrogen signaling via ERα is a target both for affecting longitudinal bone growth and bone remodeling. However, treatment with estradiol (E2) leads to an increased risk of side effects such as venous thromboembolism and breast cancer. Thus, an improved understanding of the signaling pathways of ERα will be essential in order to find better bone specific treatments with minimal adverse effects for different estrogen-related bone disorders. This review summarizes the recent data regarding the intracellular signaling mechanisms, in vivo, mediated by the ERα activation functions (AFs), AF-1 and AF-2, and the effect on bone, growth plate and other estrogen responsive tissues. In addition, we review the recent cell-specific ERα-deleted mouse models lacking ERα specifically in neuronal cells or growth plate cartilage. The newly characterized signaling pathways of estrogen, described in this review, provide a better understanding of the ERα signaling pathways, which may facilitate the design of new, bone-specific treatment strategies with minimal adverse effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Khosla S, Melton LJ 3rd, Riggs BL (2011) The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed? J Bone Miner Res 26:441–451

    PubMed  CAS  Google Scholar 

  2. Lindberg MK, Weihua Z, Andersson N, Moverare S, Gao H, Vidal O, Erlandsson M, Windahl S, Andersson G, Lubahn DB, Carlsten H, Dahlman-Wright K, Gustafsson JA, Ohlsson C (2002) Estrogen receptor specificity for the effects of estrogen in ovariectomized mice. J Endocrinol 174:167–178

    PubMed  CAS  Google Scholar 

  3. MacGillivray MH, Morishima A, Conte F, Grumbach M, Smith EP (1998) Pediatric endocrinology update: an overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover: lessons from mutations in the genes for aromatase and the estrogen receptor. Horm Res 49(Suppl 1):2–8

    PubMed  CAS  Google Scholar 

  4. Moverare S, Venken K, Eriksson AL, Andersson N, Skrtic S, Wergedal J, Mohan S, Salmon P, Bouillon R, Gustafsson JA, Vanderschueren D, Ohlsson C (2003) Differential effects on bone of estrogen receptor alpha and androgen receptor activation in orchidectomized adult male mice. Proc Natl Acad Sci USA 100:13573–13578

    PubMed  CAS  Google Scholar 

  5. Sims NA, Clement-Lacroix P, Minet D, Fraslon-Vanhulle C, Gaillard-Kelly M, Resche-Rigon M, Baron R (2003) A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. J Clin Invest 111:1319–1327

    PubMed  CAS  Google Scholar 

  6. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056–1061

    PubMed  CAS  Google Scholar 

  7. Vandenput L, Ohlsson C (2009) Estrogens as regulators of bone health in men. Nat Rev Endocrinol 5:437–443

    PubMed  CAS  Google Scholar 

  8. Vidal O, Lindberg MK, Hollberg K, Baylink DJ, Andersson G, Lubahn DB, Mohan S, Gustafsson JA, Ohlsson C (2000) Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc Natl Acad Sci USA 97:5474–5479

    PubMed  CAS  Google Scholar 

  9. Juul A (2001) The effects of oestrogens on linear bone growth. Hum Reprod Update 7:303–313

    PubMed  CAS  Google Scholar 

  10. Ettinger B (1988) Prevention of osteoporosis: treatment of estradiol deficiency. Obstet Gynecol 72:12S–17S

    PubMed  CAS  Google Scholar 

  11. Farhat MY, Lavigne MC, Ramwell PW (1996) The vascular protective effects of estrogen. FASEB J 10:615–624

    PubMed  CAS  Google Scholar 

  12. Gillies GE, McArthur S (2010) Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev 62:155–198

    PubMed  CAS  Google Scholar 

  13. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863–870

    PubMed  CAS  Google Scholar 

  14. Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350:1047–1059

    Google Scholar 

  15. Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S (1996) Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 348:977–980

    PubMed  CAS  Google Scholar 

  16. Chagin AS, Chrysis D, Takigawa M, Ritzen EM, Savendahl L (2006) Locally produced estrogen promotes fetal rat metatarsal bone growth; an effect mediated through increased chondrocyte proliferation and decreased apoptosis. J Endocrinol 188:193–203

    PubMed  CAS  Google Scholar 

  17. Kronenberg HM (2003) Developmental regulation of the growth plate. Nature 423:332–336

    PubMed  CAS  Google Scholar 

  18. Stevens DA, Williams GR (1999) Hormone regulation of chondrocyte differentiation and endochondral bone formation. Mol Cell Endocrinol 151:195–204

    PubMed  CAS  Google Scholar 

  19. van der Eerden BC, Karperien M, Wit JM (2003) Systemic and local regulation of the growth plate. Endocr Rev 24:782–801

    PubMed  Google Scholar 

  20. Jansson JO, Eden S, Isaksson O (1985) Sexual dimorphism in the control of growth hormone secretion. Endocr Rev 6:128–150

    PubMed  CAS  Google Scholar 

  21. Ohlsson C, Mohan S, Sjogren K, Tivesten A, Isgaard J, Isaksson O, Jansson JO, Svensson J (2009) The role of liver-derived insulin-like growth factor-I. Endocr Rev 30:494–535

    PubMed  CAS  Google Scholar 

  22. Veldhuis JD, Metzger DL, Martha PM Jr, Mauras N, Kerrigan JR, Keenan B, Rogol AD, Pincus SM (1997) Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab 82:3414–3420

    PubMed  CAS  Google Scholar 

  23. Bilezikian JP, Morishima A, Bell J, Grumbach MM (1998) Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 339:599–603

    PubMed  CAS  Google Scholar 

  24. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS, Simpson ER (1997) Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337:91–95

    PubMed  CAS  Google Scholar 

  25. Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER (1994) A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab 78:1287–1292

    PubMed  CAS  Google Scholar 

  26. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689–3698

    PubMed  CAS  Google Scholar 

  27. Smith EP, Specker B, Bachrach BE, Kimbro KS, Li XJ, Young MF, Fedarko NS, Abuzzahab MJ, Frank GR, Cohen RM, Lubahn DB, Korach KS (2008) Impact on bone of an estrogen receptor-alpha gene loss of function mutation. J Clin Endocrinol Metab 93:3088–3096

    PubMed  CAS  Google Scholar 

  28. Weise M, De-Levi S, Barnes KM, Gafni RI, Abad V, Baron J (2001) Effects of estrogen on growth plate senescence and epiphyseal fusion. Proc Natl Acad Sci USA 98:6871–6876

    PubMed  CAS  Google Scholar 

  29. Raisz LG (1999) Physiology and pathophysiology of bone remodeling. Clin Chem 45:1353–1358

    PubMed  CAS  Google Scholar 

  30. Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL (2003) Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111:1221–1230

    PubMed  CAS  Google Scholar 

  31. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL (1999) Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 140:4367–4370

    PubMed  CAS  Google Scholar 

  32. Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, Pacifici R (2001) Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 98:13960–13965

    PubMed  CAS  Google Scholar 

  33. Almeida M, Han L, Martin-Millan M, Plotkin LI, Stewart SA, Roberson PK, Kousteni S, O’Brien CA, Bellido T, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC (2007) Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem 282:27285–27297

    PubMed  CAS  Google Scholar 

  34. Dang ZC, van Bezooijen RL, Karperien M, Papapoulos SE, Lowik CW (2002) Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner Res 17:394–405

    PubMed  CAS  Google Scholar 

  35. Okazaki R, Inoue D, Shibata M, Saika M, Kido S, Ooka H, Tomiyama H, Sakamoto Y, Matsumoto T (2002) Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology 143:2349–2356

    PubMed  CAS  Google Scholar 

  36. Khosla S, Oursler MJ, Monroe DG (2012) Estrogen and the skeleton. Trends Endocrinol Metab 23:576–581

    PubMed  CAS  Google Scholar 

  37. Qu Q, Perala-Heape M, Kapanen A, Dahllund J, Salo J, Vaananen HK, Harkonen P (1998) Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone 22:201–209

    PubMed  CAS  Google Scholar 

  38. Martin-Millan M, Almeida M, Ambrogini E, Han L, Zhao H, Weinstein RS, Jilka RL, O’Brien CA, Manolagas SC (2010) The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol 24:323–334

    PubMed  CAS  Google Scholar 

  39. Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y, Nishina H, Takeda S, Takayanagi H, Metzger D, Kanno J, Takaoka K, Martin TJ, Chambon P, Kato S (2007) Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130:811–823

    PubMed  CAS  Google Scholar 

  40. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF (1996) Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med 2:1132–1136

    PubMed  CAS  Google Scholar 

  41. Oursler MJ, Osdoby P, Pyfferoen J, Riggs BL, Spelsberg TC (1991) Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci USA 88:6613–6617

    PubMed  CAS  Google Scholar 

  42. Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M, Nakamaru Y, Hiroi E, Hiura K, Kameda A, Yang NN, Hakeda Y, Kumegawa M (1997) Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 186:489–495

    PubMed  CAS  Google Scholar 

  43. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P (1986) Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320:134–139

    PubMed  CAS  Google Scholar 

  44. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J (1986) Sequence and expression of human estrogen receptor complementary DNA. Science 231:1150–1154

    PubMed  CAS  Google Scholar 

  45. Jensen EV (1962) On the mechanism of estrogen action. Perspect Biol Med 6:47–59

    PubMed  CAS  Google Scholar 

  46. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925–5930

    PubMed  CAS  Google Scholar 

  47. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625–1630

    PubMed  CAS  Google Scholar 

  48. Thomas P, Pang Y, Filardo EJ, Dong J (2005) Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146:624–632

    PubMed  CAS  Google Scholar 

  49. Filardo EJ, Thomas P (2012) Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. Endocrinology 153:2953–2962

    PubMed  CAS  Google Scholar 

  50. Langer G, Bader B, Meoli L, Isensee J, Delbeck M, Noppinger PR, Otto C (2010) A critical review of fundamental controversies in the field of GPR30 research. Steroids 75:603–610

    PubMed  CAS  Google Scholar 

  51. Levin ER (2009) G protein-coupled receptor 30: estrogen receptor or collaborator? Endocrinology 150:1563–1565

    PubMed  CAS  Google Scholar 

  52. Otto C, Fuchs I, Kauselmann G, Kern H, Zevnik B, Andreasen P, Schwarz G, Altmann H, Klewer M, Schoor M, Vonk R, Fritzemeier KH (2009) GPR30 does not mediate estrogenic responses in reproductive organs in mice. Biol Reprod 80:34–41

    PubMed  CAS  Google Scholar 

  53. Otto C, Rohde-Schulz B, Schwarz G, Fuchs I, Klewer M, Brittain D, Langer G, Bader B, Prelle K, Nubbemeyer R, Fritzemeier KH (2008) G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol. Endocrinology 149:4846–4856

    PubMed  CAS  Google Scholar 

  54. Pettersson K, Grandien K, Kuiper GG, Gustafsson JA (1997) Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol Endocrinol 11:1486–1496

    PubMed  CAS  Google Scholar 

  55. Pace P, Taylor J, Suntharalingam S, Coombes RC, Ali S (1997) Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha. J Biol Chem 272:25832–25838

    PubMed  CAS  Google Scholar 

  56. Tora L, White J, Brou C, Tasset D, Webster N, Scheer E, Chambon P (1989) The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59:477–487

    PubMed  CAS  Google Scholar 

  57. Krust A, Green S, Argos P, Kumar V, Walter P, Bornert JM, Chambon P (1986) The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors. EMBO J 5:891–897

    PubMed  CAS  Google Scholar 

  58. Flouriot G, Brand H, Denger S, Metivier R, Kos M, Reid G, Sonntag-Buck V, Gannon F (2000) Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. EMBO J 19:4688–4700

    PubMed  CAS  Google Scholar 

  59. Berry M, Metzger D, Chambon P (1990) Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J 9:2811–2818

    PubMed  CAS  Google Scholar 

  60. Green S, Chambon P (1988) Nuclear receptors enhance our understanding of transcription regulation. Trends Genet 4:309–314

    PubMed  CAS  Google Scholar 

  61. Pike AC (2006) Lessons learnt from structural studies of the oestrogen receptor. Best Pract Res Clin Endocrinol Metab 20:1–14

    PubMed  CAS  Google Scholar 

  62. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753–758

    PubMed  CAS  Google Scholar 

  63. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL (1998) The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927–937

    PubMed  CAS  Google Scholar 

  64. Hall JM, McDonnell DP (1999) The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140:5566–5578

    PubMed  CAS  Google Scholar 

  65. Tremblay A, Tremblay GB, Labrie F, Giguere V (1999) Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. Mol Cell 3:513–519

    PubMed  CAS  Google Scholar 

  66. Gronemeyer H, Laudet V (1995) Transcription factors 3: nuclear receptors. Protein Profile 2:1173–1308

    PubMed  CAS  Google Scholar 

  67. Kraus WL, McInerney EM, Katzenellenbogen BS (1995) Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor. Proc Natl Acad Sci USA 92:12314–12318

    PubMed  CAS  Google Scholar 

  68. Metzger D, Losson R, Bornert JM, Lemoine Y, Chambon P (1992) Promoter specificity of the two transcriptional activation functions of the human oestrogen receptor in yeast. Nucleic Acids Res 20:2813–2817

    PubMed  CAS  Google Scholar 

  69. Borjesson AE, Windahl SH, Lagerquist MK, Engdahl C, Frenkel B, Moverare-Skrtic S, Sjogren K, Kindblom JM, Stubelius A, Islander U, Antal MC, Krust A, Chambon P, Ohlsson C (2011) Roles of transactivating functions 1 and 2 of estrogen receptor-alpha in bone. Proc Natl Acad Sci USA 108:6288–6293

    PubMed  CAS  Google Scholar 

  70. Windahl SH, Andersson N, Chagin AS, Martensson UE, Carlsten H, Olde B, Swanson C, Moverare-Skrtic S, Savendahl L, Lagerquist MK, Leeb-Lundberg LM, Ohlsson C (2009) The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice. Am J Physiol Endocrinol Metab 296:E490–E496

    PubMed  CAS  Google Scholar 

  71. Sims NA, Dupont S, Krust A, Clement-Lacroix P, Minet D, Resche-Rigon M, Gaillard-Kelly M, Baron R (2002) Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone 30:18–25

    PubMed  CAS  Google Scholar 

  72. Windahl SH, Hollberg K, Vidal O, Gustafsson JA, Ohlsson C, Andersson G (2001) Female estrogen receptor beta−/− mice are partially protected against age-related trabecular bone loss. J Bone Miner Res 16:1388–1398

    PubMed  CAS  Google Scholar 

  73. Windahl SH, Vidal O, Andersson G, Gustafsson JA, Ohlsson C (1999) Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(−/−) mice. J Clin Invest 104:895–901

    PubMed  CAS  Google Scholar 

  74. Lindberg MK, Moverare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson JA, Ohlsson C (2003) Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a “ying yang” relationship between ERalpha and ERbeta in mice. Mol Endocrinol 17:203–208

    PubMed  CAS  Google Scholar 

  75. van der Eerden BC, Gevers EF, Lowik CW, Karperien M, Wit JM (2002) Expression of estrogen receptor alpha and beta in the epiphyseal plate of the rat. Bone 30:478–485

    PubMed  Google Scholar 

  76. van der Eerden BC, Lowik CW, Wit JM, Karperien M (2004) Expression of estrogen receptors and enzymes involved in sex steroid metabolism in the rat tibia during sexual maturation. J Endocrinol 180:457–467

    PubMed  Google Scholar 

  77. Zaman G, Jessop HL, Muzylak M, De Souza RL, Pitsillides AA, Price JS, Lanyon LL (2006) Osteocytes use estrogen receptor alpha to respond to strain but their ERalpha content is regulated by estrogen. J Bone Miner Res 21:1297–1306

    PubMed  CAS  Google Scholar 

  78. Ushiyama T, Ueyama H, Inoue K, Ohkubo I, Hukuda S (1999) Expression of genes for estrogen receptors alpha and beta in human articular chondrocytes. Osteoarthritis Cartilage 7:560–566

    PubMed  CAS  Google Scholar 

  79. Vidal O, Kindblom LG, Ohlsson C (1999) Expression and localization of estrogen receptor-beta in murine and human bone. J Bone Miner Res 14:923–929

    PubMed  CAS  Google Scholar 

  80. Gajda M, Litwin JA, Cichocki T, Timmermans JP, Adriaensen D (2005) Development of sensory innervation in rat tibia: co-localization of CGRP and substance P with growth-associated protein 43 (GAP-43). J Anat 207:135–144

    PubMed  CAS  Google Scholar 

  81. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197–207

    PubMed  CAS  Google Scholar 

  82. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434:514–520

    PubMed  CAS  Google Scholar 

  83. Takeda S, Karsenty G (2008) Molecular bases of the sympathetic regulation of bone mass. Bone 42:837–840

    PubMed  CAS  Google Scholar 

  84. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Strom A, Treuter E, Warner M, Gustafsson JA (2007) Estrogen receptors: how do they signal and what are their targets. Physiol Rev 87:905–931

    PubMed  CAS  Google Scholar 

  85. Meyer ME, Gronemeyer H, Turcotte B, Bocquel MT, Tasset D, Chambon P (1989) Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57:433–442

    PubMed  CAS  Google Scholar 

  86. Onate SA, Tsai SY, Tsai MJ, O’Malley BW (1995) Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354–1357

    PubMed  CAS  Google Scholar 

  87. Gruber CJ, Gruber DM, Gruber IM, Wieser F, Huber JC (2004) Anatomy of the estrogen response element. Trends Endocrinol Metab 15:73–78

    PubMed  CAS  Google Scholar 

  88. Chinenov Y, Kerppola TK (2001) Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20:2438–2452

    PubMed  CAS  Google Scholar 

  89. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, Webb P (2000) Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74:311–317

    PubMed  CAS  Google Scholar 

  90. Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G, Gustafsson JA, Safe S (2000) Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 275:5379–5387

    PubMed  CAS  Google Scholar 

  91. Rickard DJ, Subramaniam M, Spelsberg TC (1999) Molecular and cellular mechanisms of estrogen action on the skeleton. J Cell Biochem Suppl 32–33:123–132

    Google Scholar 

  92. Segars JH, Driggers PH (2002) Estrogen action and cytoplasmic signaling cascades. Part I: membrane-associated signaling complexes. Trends Endocrinol Metab 13:349–354

    PubMed  CAS  Google Scholar 

  93. Pedram A, Razandi M, Levin ER (2006) Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 20:1996–2009

    PubMed  CAS  Google Scholar 

  94. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P (1995) Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491–1494

    PubMed  CAS  Google Scholar 

  95. Driggers PH, Segars JH (2002) Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling. Trends Endocrinol Metab 13:422–427

    PubMed  CAS  Google Scholar 

  96. Curtis SW, Washburn T, Sewall C, DiAugustine R, Lindzey J, Couse JF, Korach KS (1996) Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc Natl Acad Sci USA 93:12626–12630

    PubMed  CAS  Google Scholar 

  97. Newton CJ, Buric R, Trapp T, Brockmeier S, Pagotto U, Stalla GK (1994) The unliganded estrogen receptor (ER) transduces growth factor signals. J Steroid Biochem Mol Biol 48:481–486

    PubMed  CAS  Google Scholar 

  98. Lannigan DA (2003) Estrogen receptor phosphorylation. Steroids 68:1–9

    PubMed  CAS  Google Scholar 

  99. Murphy LC, Seekallu SV, Watson PH (2011) Clinical significance of estrogen receptor phosphorylation. Endocr Relat Cancer 18:R1–R14

    PubMed  CAS  Google Scholar 

  100. Drop SL, De Waal WJ, De Muinck Keizer-Schrama SM (1998) Sex steroid treatment of constitutionally tall stature. Endocr Rev 19:540–558

    PubMed  CAS  Google Scholar 

  101. Karimian E, Savendahl L (2011) Estrogen signaling in growth plate cartilage. Endocr Dev 21:42–51

    PubMed  CAS  Google Scholar 

  102. Hero M, Norjavaara E, Dunkel L (2005) Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial. J Clin Endocrinol Metab 90:6396–6402

    PubMed  CAS  Google Scholar 

  103. Hendriks AE, Drop SL, Laven JS, Boot AM (2012) Fertility of tall girls treated with high-dose estrogen, a dose-response relationship. J Clin Endocrinol Metab 97:3107–3114

    Google Scholar 

  104. Hendriks AE, Laven JS, Valkenburg O, Fong SL, Fauser BC, de Ridder MA, de Jong FH, Visser JA, van Ginneken AM, Boot AM, Drop SL (2011) Fertility and ovarian function in high-dose estrogen-treated tall women. J Clin Endocrinol Metab 96:1098–1105

    PubMed  CAS  Google Scholar 

  105. Venn A, Bruinsma F, Werther G, Pyett P, Baird D, Jones P, Rayner J, Lumley J (2004) Oestrogen treatment to reduce the adult height of tall girls: long-term effects on fertility. Lancet 364:1513–1518

    PubMed  CAS  Google Scholar 

  106. Rookus MA, van Leeuwen FE (1994) Oral contraceptives and risk of breast cancer in women aged 20–54 years. Netherlands oral contraceptives and breast cancer study group. Lancet 344:844–851

    PubMed  CAS  Google Scholar 

  107. Hero M, Makitie O, Kroger H, Nousiainen E, Toiviainen-Salo S, Dunkel L (2009) Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature. Horm Res 71:290–297

    PubMed  CAS  Google Scholar 

  108. Fornander T, Rutqvist LE, Cedermark B, Glas U, Mattsson A, Silfversward C, Skoog L, Somell A, Theve T, Wilking N et al (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1:117–120

    PubMed  CAS  Google Scholar 

  109. Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, Carbone PP, DeMets DL (1992) Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326:852–856

    PubMed  CAS  Google Scholar 

  110. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple outcomes of raloxifene evaluation (MORE) investigators. JAMA 282:637–645

    PubMed  CAS  Google Scholar 

  111. Cummings SR, Ensrud K, Delmas PD, LaCroix AZ, Vukicevic S, Reid DM, Goldstein S, Sriram U, Lee A, Thompson J, Armstrong RA, Thompson DD, Powles T, Zanchetta J, Kendler D, Neven P, Eastell R (2010) Lasofoxifene in postmenopausal women with osteoporosis. N Engl J Med 362:686–696

    PubMed  CAS  Google Scholar 

  112. Silverman SL, Chines AA, Kendler DL, Kung AW, Teglbjaerg CS, Felsenberg D, Mairon N, Constantine GD, Adachi JD (2012) Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study. Osteoporos Int 23:351–363

    PubMed  CAS  Google Scholar 

  113. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M (1994) Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264:1455–1458

    PubMed  CAS  Google Scholar 

  114. Smith CL, Nawaz Z, O’Malley BW (1997) Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol 11:657–666

    PubMed  CAS  Google Scholar 

  115. Nettles KW, Greene GL (2005) Ligand control of coregulator recruitment to nuclear receptors. Annu Rev Physiol 67:309–333

    PubMed  CAS  Google Scholar 

  116. Windahl SH, Andersson G, Gustafsson JA (2002) Elucidation of estrogen receptor function in bone with the use of mouse models. Trends Endocrinol Metab 13:195–200

    PubMed  CAS  Google Scholar 

  117. Syed F, Khosla S (2005) Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun 328:688–696

    PubMed  CAS  Google Scholar 

  118. Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C (2004) Androgens and bone. Endocr Rev 25:389–425

    PubMed  CAS  Google Scholar 

  119. Billon-Gales A, Fontaine C, Filipe C, Douin-Echinard V, Fouque MJ, Flouriot G, Gourdy P, Lenfant F, Laurell H, Krust A, Chambon P, Arnal JF (2009) The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17beta-estradiol. Proc Natl Acad Sci USA 106:2053–2058

    PubMed  CAS  Google Scholar 

  120. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M (2000) Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 127:4277–4291

    PubMed  CAS  Google Scholar 

  121. Modder UI, Sanyal A, Kearns AE, Sibonga JD, Nishihara E, Xu J, O’Malley BW, Ritman EL, Riggs BL, Spelsberg TC, Khosla S (2004) Effects of loss of steroid receptor coactivator-1 on the skeletal response to estrogen in mice. Endocrinology 145:913–921

    PubMed  Google Scholar 

  122. Bebermeier JH, Brooks JD, DePrimo SE, Werner R, Deppe U, Demeter J, Hiort O, Holterhus PM (2006) Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription. J Mol Med (Berl) 84:919–931

    CAS  Google Scholar 

  123. Ghosh S, Thakur MK (2008) Tissue-specific expression of receptor-interacting protein in aging mouse. Age (Dordr) 30:237–243

    CAS  Google Scholar 

  124. Smith CL, O’Malley BW (2004) Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 25:45–71

    PubMed  CAS  Google Scholar 

  125. Metivier R, Penot G, Flouriot G, Pakdel F (2001) Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains. Mol Endocrinol 15:1953–1970

    PubMed  CAS  Google Scholar 

  126. Shang Y, Brown M (2002) Molecular determinants for the tissue specificity of SERMs. Science 295:2465–2468

    PubMed  CAS  Google Scholar 

  127. Borjesson AE, Farman HH, Engdahl C, Koskela A, Sjogren K, Kindblom JM, Stubelius A, Islander U, Carlsten H, Antal MC, Krust A, Chambon P, Tuukkanen J, Lagerquist MK, Windahl SH, Ohlsson C (2012) The role of activation functions 1 and 2 of estrogen receptor-a for the effects of estradiol and selective estrogen receptor modulators (SERMs) in male mice. J Bone Miner Res [Epub ahead of print]

  128. Vanderschueren D, Boonen S, Ederveen AG, de Coster R, Van Herck E, Moermans K, Vandenput L, Verstuyf A, Bouillon R (2000) Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model. Bone 27:611–617

    PubMed  CAS  Google Scholar 

  129. Couse JF, Curtis SW, Washburn TF, Lindzey J, Golding TS, Lubahn DB, Smithies O, Korach KS (1995) Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol Endocrinol 9:1441–1454

    PubMed  CAS  Google Scholar 

  130. Chagin AS, Lindberg MK, Andersson N, Moverare S, Gustafsson JA, Savendahl L, Ohlsson C (2004) Estrogen receptor-beta inhibits skeletal growth and has the capacity to mediate growth plate fusion in female mice. J Bone Miner Res 19:72–77

    PubMed  CAS  Google Scholar 

  131. Parikka V, Peng Z, Hentunen T, Risteli J, Elo T, Vaananen HK, Harkonen P (2005) Estrogen responsiveness of bone formation in vitro and altered bone phenotype in aged estrogen receptor-alpha-deficient male and female mice. Eur J Endocrinol 152:301–314

    PubMed  CAS  Google Scholar 

  132. Borjesson AE, Windahl SH, Karimian E, Eriksson EE, Lagerquist MK, Engdahl C, Antal MC, Krust A, Chambon P, Savendahl L, Ohlsson C (2012) The role of estrogen receptor-alpha and its activation function-1 for growth plate closure in female mice. Am J Physiol Endocrinol Metab 302:E1381–E1389

    PubMed  CAS  Google Scholar 

  133. Denger S, Reid G, Kos M, Flouriot G, Parsch D, Brand H, Korach KS, Sonntag-Buck V, Gannon F (2001) ERalpha gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins. Mol Endocrinol 15:2064–2077

    PubMed  CAS  Google Scholar 

  134. Kos M, Denger S, Reid G, Korach KS, Gannon F (2002) Down but not out? A novel protein isoform of the estrogen receptor alpha is expressed in the estrogen receptor alpha knockout mouse. J Mol Endocrinol 29:281–286

    PubMed  CAS  Google Scholar 

  135. Borjesson AE, Lagerquist MK, Liu C, Shao R, Windahl SH, Karlsson C, Sjogren K, Moverare-Skrtic S, Antal MC, Krust A, Mohan S, Chambon P, Savendahl L, Ohlsson C (2010) The role of estrogen receptor alpha in growth plate cartilage for longitudinal bone growth. J Bone Miner Res 25:2690–2700

    PubMed  Google Scholar 

  136. Ovchinnikov DA, Deng JM, Ogunrinu G, Behringer RR (2000) Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice. Genesis 26:145–146

    PubMed  CAS  Google Scholar 

  137. Ohlsson C, Engdahl C, Borjesson AE, Windahl SH, Studer E, Westberg L, Eriksson E, Koskela A, Tuukkanen J, Krust A, Chambon P, Carlsten H, Lagerquist MK (2012) Estrogen receptor-alpha expression in neuronal cells affects bone mass. Proc Natl Acad Sci USA 109:983–988

    PubMed  CAS  Google Scholar 

  138. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R, Klein R, Schutz G (1999) Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23:99–103

    PubMed  CAS  Google Scholar 

  139. Nomura M, Akama KT, Alves SE, Korach KS, Gustafsson JA, Pfaff DW, Ogawa S (2005) Differential distribution of estrogen receptor (ER)-alpha and ER-beta in the midbrain raphe nuclei and periaqueductal gray in male mouse: predominant role of ER-beta in midbrain serotonergic systems. Neuroscience 130:445–456

    PubMed  CAS  Google Scholar 

  140. Finan B, Yang B, Ottaway N, Stemmer K, Muller TD, Yi CX, Habegger K, Schriever SC, Garcia-Caceres C, Kabra DG, Hembree J, Holland J, Raver C, Seeley RJ, Hans W, Irmler M, Beckers J, de Angelis MH, Tiano JP, Mauvais-Jarvis F, Perez-Tilve D, Pfluger P, Zhang L, Gelfanov V, Dimarchi RD, Tschop MH (2012) Targeted estrogen delivery reverses the metabolic syndrome. Nat Med 18:1847–1856

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    A. E. Börjesson, M. K. Lagerquist, S. H. Windahl & C. Ohlsson

Authors
  1. A. E. Börjesson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. K. Lagerquist
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. H. Windahl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Ohlsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Ohlsson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Börjesson, A.E., Lagerquist, M.K., Windahl, S.H. et al. The role of estrogen receptor α in the regulation of bone and growth plate cartilage. Cell. Mol. Life Sci. 70, 4023–4037 (2013). https://doi.org/10.1007/s00018-013-1317-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-013-1317-1

Keywords

Search

Navigation